The Lancet Group

The Lancet Haematology in conversation with

Unisciti agli editori di The Lancet Haematology mentre discutono ricerche innovative con gli autori, affrontando questioni sanitarie fondamentali e le loro implicazioni per le politiche e la cura.

Listen on Apple Podcasts

Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma

16 mins • Apr 28, 2025

Episodi recenti

Apr 28, 2025

Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma

16 mins

Mar 31, 2025

Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia

18 mins

Mar 3, 2025

Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe

27 mins

Jan 29, 2025

Dawn Swan on air pollution and venous thromboembolism

15 mins

Jan 16, 2025

Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis

16 mins

Lingua
Inglese
Paese
Stati Uniti
Feed Host
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.